caffeine has been researched along with Amyotonia Congenita in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using the skinned fiber preparation, the response to caffeine was studied on the skeletal muscle of malignant hyperthermia or other neuromuscular diseases." | 7.66 | Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers. ( Ishihara, T; Nonaka, I; Sugita, H; Sunohara, N; Takagi, A, 1983) |
| "The association of malignant hyperthermia (MH) with neuromuscular disorders has been recognized since 1970." | 5.27 | Halothane-caffeine contracture testing in neuromuscular diseases. ( Fletcher, JE; Heiman-Patterson, TD; Rosenberg, H; Tahmoush, AJ, 1988) |
| "Using the skinned fiber preparation, the response to caffeine was studied on the skeletal muscle of malignant hyperthermia or other neuromuscular diseases." | 3.66 | Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers. ( Ishihara, T; Nonaka, I; Sugita, H; Sunohara, N; Takagi, A, 1983) |
| "The association of malignant hyperthermia (MH) with neuromuscular disorders has been recognized since 1970." | 1.27 | Halothane-caffeine contracture testing in neuromuscular diseases. ( Fletcher, JE; Heiman-Patterson, TD; Rosenberg, H; Tahmoush, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassol, G | 1 |
| Godinho, DB | 1 |
| de Zorzi, VN | 1 |
| Farinha, JB | 1 |
| Della-Pace, ID | 1 |
| de Carvalho Gonçalves, M | 1 |
| Oliveira, MS | 1 |
| Furian, AF | 1 |
| Fighera, MR | 1 |
| Royes, LFF | 1 |
| Haraki, T | 1 |
| Yasuda, T | 1 |
| Mukaida, K | 1 |
| Migita, T | 1 |
| Hamada, H | 1 |
| Kawamoto, M | 1 |
| Takagi, A | 1 |
| Sunohara, N | 1 |
| Ishihara, T | 1 |
| Nonaka, I | 1 |
| Sugita, H | 1 |
| Mortier, W | 2 |
| Biesel, C | 1 |
| Adnet, PJ | 1 |
| Krivosic-Horber, RM | 1 |
| Krivosic, I | 2 |
| Haudecoeur, G | 1 |
| Reyford, HG | 1 |
| Adamantidis, MM | 1 |
| Medahoui, H | 1 |
| Hopkins, PM | 1 |
| Ellis, FR | 1 |
| Halsall, PJ | 1 |
| Takamori, M | 1 |
| Gruener, R | 2 |
| Stern, LZ | 2 |
| Baumbach, N | 1 |
| Il'ina, NA | 1 |
| Poliakova, NF | 1 |
| Khokhlov, AP | 1 |
| Ehle, AL | 1 |
| Heytens, L | 1 |
| Martin, JJ | 1 |
| Van de Kelft, E | 1 |
| Bossaert, LL | 1 |
| Krivosic-Horber, R | 1 |
| Heiman-Patterson, TD | 1 |
| Rosenberg, H | 1 |
| Fletcher, JE | 1 |
| Tahmoush, AJ | 1 |
| van Gennip, AH | 1 |
| de Bree, PK | 1 |
| van der Heiden, C | 1 |
| Wadman, SK | 1 |
| Haverkamp, J | 1 |
| Vliegenthart, JF | 1 |
3 reviews available for caffeine and Amyotonia Congenita
| Article | Year |
|---|---|
Potential therapeutic implications of ergogenic compounds on pathophysiology induced by traumatic brain injury: A narrative review.
Topics: Animals; Arginine; Brain Injuries, Traumatic; Caffeine; Carnitine; Central Nervous System Stimulants | 2019 |
[Relationship between neuromuscular transmission and active amines--electromyographic informations].
Topics: Acetylcholine; Animals; Biogenic Amines; Caffeine; Calcium; Cats; Cyclic AMP; Dopamine; Electromyogr | 1975 |
Malignant hyperthermia: relation to other diseases.
Topics: Caffeine; Calcium Channels; Diagnosis, Differential; Halothane; Humans; Malignant Hyperthermia; Musc | 1990 |
12 other studies available for caffeine and Amyotonia Congenita
| Article | Year |
|---|---|
Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1).
Topics: Animals; Caffeine; Calcium; Genetic Variation; HEK293 Cells; Humans; Malignant Hyperthermia; Muscle | 2011 |
Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
Topics: Adolescent; Adult; Aged; Caffeine; Child; Humans; In Vitro Techniques; Malignant Hyperthermia; Middl | 1983 |
Pharmacological in-vitro studies in malignant hyperthermia in childhood.
Topics: Adolescent; Biopsy; Caffeine; Child; Child, Preschool; Dose-Response Relationship, Drug; Halothane; | 1982 |
Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Me | 1994 |
Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Topics: Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Tech | 1993 |
Caffeine-modulated acetylcholine sensitivity in denervated rat and diseased human muscle.
Topics: Acetylcholine; Action Potentials; Animals; Caffeine; Calcium; Cyclic AMP; Drug Synergism; Humans; Me | 1975 |
[Pathogenesis of creatinuria and aminoaciduria in neuromuscular diseases].
Topics: Adolescent; Adult; Amino Acids; Amyotrophic Lateral Sclerosis; Caffeine; Child; Child, Preschool; Cr | 1977 |
Motor neuron disease: possible mechanisms of spontaneous electromyographic activity.
Topics: Adult; Caffeine; Calcium; Electromyography; Humans; Male; Middle Aged; Motor Neurons; Muscles; Neuro | 1976 |
In vitro contracture tests in patients with various neuromuscular diseases.
Topics: Adolescent; Adult; Aged; Caffeine; Child; Child, Preschool; Disease Susceptibility; Drug Hypersensit | 1992 |
[Central core disease associated with malignant hyperthermia sensitivity].
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Child, Preschool; Creatine Kinase; Female; Halotha | 1989 |
Halothane-caffeine contracture testing in neuromuscular diseases.
Topics: Biopsy; Caffeine; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction; Muscles; Neuromuscu | 1988 |
Urinary excretion of 3 -methylxanthine and related compounds in children.
Topics: Adolescent; Adult; Cacao; Caffeine; Child; Child, Preschool; Chromatography, Ion Exchange; Chromatog | 1973 |